Stock Analysis

Top Penny Stocks To Watch In May 2025

NasdaqCM:KRMD
Source: Shutterstock

As the U.S. stock market experiences a positive streak, with the Dow Jones and S&P 500 rising for the eighth consecutive day, investors are keenly observing how major tech earnings influence broader economic sentiment. Penny stocks, though often overlooked due to their historical connotations, remain relevant as potential investment opportunities in this dynamic landscape. These stocks typically represent smaller or newer companies and can offer unexpected growth potential when supported by strong financial fundamentals. In this article, we explore several penny stocks that may stand out for their financial robustness and long-term promise.

Top 10 Penny Stocks In The United States

NameShare PriceMarket CapRewards & Risks
Safe Bulkers (NYSE:SB)$3.39$354.37M✅ 3 ⚠️ 3 View Analysis >
Tuya (NYSE:TUYA)$2.35$1.19B✅ 3 ⚠️ 3 View Analysis >
Smith Micro Software (NasdaqCM:SMSI)$0.9894$17.95M✅ 4 ⚠️ 4 View Analysis >
Kiora Pharmaceuticals (NasdaqCM:KPRX)$3.30$9.9M✅ 4 ⚠️ 1 View Analysis >
Flexible Solutions International (NYSEAM:FSI)$3.77$49.07M✅ 4 ⚠️ 2 View Analysis >
Waterdrop (NYSE:WDH)$1.31$481.01M✅ 4 ⚠️ 0 View Analysis >
TETRA Technologies (NYSE:TTI)$2.85$367.28M✅ 5 ⚠️ 2 View Analysis >
BAB (OTCPK:BABB)$0.819475$5.97M✅ 2 ⚠️ 3 View Analysis >
Lifetime Brands (NasdaqGS:LCUT)$3.625$81.25M✅ 3 ⚠️ 2 View Analysis >
CBAK Energy Technology (NasdaqCM:CBAT)$0.785$72.17M✅ 4 ⚠️ 1 View Analysis >

Click here to see the full list of 754 stocks from our US Penny Stocks screener.

Let's explore several standout options from the results in the screener.

KORU Medical Systems (NasdaqCM:KRMD)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions for the drug delivery market both in the United States and internationally, with a market cap of $126.38 million.

Operations: The company generates revenue of $33.65 million from its Surgical & Medical Equipment segment.

Market Cap: $126.38M

KORU Medical Systems, with a market cap of US$126.38 million, is navigating the penny stock landscape by focusing on strategic growth and financial stability despite current unprofitability. The company reported a net loss reduction to US$6.07 million for 2024 from US$13.74 million the previous year, signaling improved cost management. Recent developments include an extended credit facility with HSBC Ventures USA and an agreement with a global pharmaceutical firm to develop advanced infusion systems, potentially enhancing future revenue streams. KORU's experienced management and board support its strategic initiatives while maintaining sufficient cash runway for over three years.

NasdaqCM:KRMD Financial Position Analysis as at May 2025
NasdaqCM:KRMD Financial Position Analysis as at May 2025

Metalpha Technology Holding (NasdaqCM:MATH)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Metalpha Technology Holding Limited, along with its subsidiaries, offers wealth management services in Hong Kong and has a market cap of approximately $69.47 million.

Operations: The company generates revenue of $31.40 million from trading proprietary digital assets and derivative contracts.

Market Cap: $69.47M

Metalpha Technology Holding, with a market cap of US$69.47 million, has shown significant progress in the penny stock arena by becoming profitable this year, reporting a net income of US$6.04 million for the half-year ended September 2024. The company's revenue surged to US$19.72 million from US$5.09 million year-over-year, driven by trading proprietary digital assets and derivative contracts. Despite its volatile share price and an inexperienced management team, Metalpha remains debt-free with strong short-term asset coverage over liabilities and a high return on equity at 24.6%. Recent board changes include appointing CFO Pengyuan Fan as director following Ming Ni's resignation.

NasdaqCM:MATH Revenue & Expenses Breakdown as at May 2025
NasdaqCM:MATH Revenue & Expenses Breakdown as at May 2025

Applied Energetics (OTCPK:AERG)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Applied Energetics, Inc. specializes in the development and sale of advanced lasers, optical systems, and guided energy solutions for various sectors including defense and industrial markets, with a market cap of approximately $149.28 million.

Operations: The company's revenue is primarily derived from its Aerospace & Defense segment, totaling $2.43 million.

Market Cap: $149.28M

Applied Energetics, Inc., with a market cap of US$149.28 million, faces challenges typical of penny stocks, including a net loss of US$9.17 million for 2024 and an auditor's going concern doubt. Despite these hurdles, the company is advancing its strategic collaboration with Kord Technologies to develop an advanced pulsed laser system at its Tucson Battle Lab, potentially opening new defense market opportunities. Recent private placements have provided additional capital following insufficient cash runway projections based on free cash flow estimates. Though unprofitable and lacking significant revenue growth, Applied Energetics has improved its shareholder equity over five years.

OTCPK:AERG Revenue & Expenses Breakdown as at May 2025
OTCPK:AERG Revenue & Expenses Breakdown as at May 2025

Next Steps

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Valuation is complex, but we're here to simplify it.

Discover if KORU Medical Systems might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About NasdaqCM:KRMD

KORU Medical Systems

Develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally.

Excellent balance sheet with reasonable growth potential.